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Attention has been paid to phase separation of poly(lactide-co-glycolide) solutions in CH2Cl2 induced by the 
addition of a silicone oil in order to promote protein microencapsulation. Since the process is very fast, the 
system is anytime out of equilibrium. The effect of the main processing parameters on the microencapsulation 
process has been analyzed and has highlighted that kinetics of the main encapsulation steps has a great effect on 
the characteristics of the final microspheres. These results have been discussed on the basis of a physico-
chemical study of coacervation reported in previous papers of this series. 
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1. Introduction 
Poly (lactic acid) (PLA) and copolymers of lactic and glycolic acids (PLGA) are well-known biodegradable and 
histocompatible aliphatic polyesters. They are commonly used as biodegradable sutures [1-3] and they have 
more recently contributed to reconstruction of deficient or injured organs and to improved galenic formulations 
[4—6]. In this respect, they have been found suitable, in many instances, for the sustained release of drugs 'in 
vivo', for days or months. 
Ring-opening polymerization of lactides and glycolide provides a direct access to the aforementioned polyesters 
[7,8]. In contrast to the traditional step-growth polymerization of lactic and glycolic acids, this polyaddition 
mechanism allows for the perfect control of the molecular characteristics of the final polymer, such as molecular 
weight, polydispersity and end-functionality. 
During the last few years, several techniques for drug encapsulation have been developed, that currently use the 
aliphatic polyesters. A large variety of organic molecules have accordingly been encapsulated, that range from 
low molecular weight synthetic drugs to biological proteins [9]. Proteins are efficiently encapsulated by a 
modified solvent evaporation method based on double emulsions [10-12] and by a phase separation or 
coacervation process. 
This paper focuses on the coacervation technique [ 13-15], which relies upon a decrease of the solubility of the 
coating polymer by addition of a third compound to the polymer solution in an organic solvent. The point has to 
be reached where two liquid phases are formed: the rich-in polymer coacervate and the supernatant liquid phase 
depleted in polymer. If a drug is initially dispersed in the polymer solution, it can be coated by the coacervate. 
As discussed in previous papers [16-18], microencapsulation by coacervation proceeds along three main steps: 
(1) phase separation of the coating polymer solution [16], (2) adsorption of the coacervate around the drug 
particles [17], (3) solidification of the microparticles [ 18]. The main characteristic features of these three steps 
have been analyzed elsewhere under standard conditions for the preparation of poly(lactide-co-glycolide) 
microspheres. A special attention has been paid to weight, volume, composition and viscosity of the coacervate 
and supernatant phases in connection with the size distribution, surface morphology and internal porosity of the 
final microparticles [18]. Since the phase equilibrium is never reached, the system is anytime out of equilibrium. 
Therefore, the processing parameters are expected to have a significant effect on the course of this three-step 
process and ultimately on the characteristics of the final microspheres. 
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The encapsulation technique has been implemented under the following conditions. Dissolution of a random 
equimolar lactide (LA)-glycolide (GA) copolyester (PLGA 50/50) in CH2Cl2. Addition of this coating polymer 
solution with an incompatible polymer: a silicone oil of several viscosities (1000,500 and 200 cSt). Aqueous 
solutions of α-thrombin or BSA, have been dispersed in the polymer solution prior to the addition of the silicone 
oil, in view of the encapsulation of these proteinic drugs. Compared to these conditions, the effect of four main 
processing parameters has been considered in this paper: (1) volume of the dispersed aqueous phase containing 
the drug to be encapsulated, (2) addition rate of the incompatible polymer to the coating polymer solution, (3) 
stirring rate of the dispersion, (4) drug to be encapsulated. Each of the experimental parameters has been 
modified independently, and its effect on the polymer coacervation and the characteristics of the final 
microspheres (size distribution, external morphology) has been analyzed. 
 
2. Materials and methods 
2.1. Materials 
The coating polyester was supplied by Boehringer (Ingelheim, Germany), i.e. PLGA 50/50 Resomer®           
(RG 505). The 50 mol% composition was confirmed by NMR analysis. Inherent viscosity was provided by the 
supplier as 0.7 dl/g (PLGA 50/50), although solvent and temperature were undisclosed. Molecular weight (Mn) 
and polydispersity were measured by size exclusion chromatography (Hewlett-Packard 1090), in THF, at 30°C 
and found to be 20 000 and 2.2, respectively, by reference to a polystyrene calibration. 
Silicone oils of several viscosity grades (200, 500, 1000 cSt) were purchased from Dow Corning (Seneffe, 
Belgium). Methylene chloride (p.a.) was used as solvent for PLGA 50/50, and indigo carmine (p.a.) as a dye 
selectively soluble in the dispersed aqueous phase. They were purchased from Merck (Darmstadt, Germany). 
Bovine Serum Albumin (A-7906), or BSA, and α-thrombin (T4648) were supplied by Sigma Chemie (Bornem, 
Belgium) as powdery lyophilisates. 
2.2. Methods 
Phase diagrams and microscopic observations [16] 
2 g of PLGA 50/50 were dissolved in 25 g of methylene chloride at 25°C in a flask fitted with a rubber septum. 
Various volumes of a saturated solution of indigo carmine in water (150 µl, 300 µl, 600 µl, 1.5 ml and 3 ml) 
were dispersed in the organic solution under magnetic stirring. Phase separation of the polymer solution was 
induced by the stepwise addition of the 1000 cSt silicone oil (1 ml increments) and followed by observation by 
optical microscopy (Leitz-Orthoplan). The encapsulation efficiency was estimated from the extent of the coating 
of the dispersed aqueous phase by the coacervate. 
Weight and volume of the separated phases 
This method was reported elsewhere [16]. Briefly, 2 wt% solution of the PLGA 50/50 in CH2C12 (1 g PLGA 
50/50) was added into a glass vessel covered by a lid with two holes [12]. The central hole allowed a stirring 
screw to be connected to a driving motor (IKA type kw) (200 rpm) and the four-pitched blade impeller was 
located a few millimetres above the bottom of the vessel. 
The 1000 cSt silicone oil was added to the polymer solution throughout the second hole at different rates (18; 
5.7; 1.4; 0.65 ml/min). Coacervate and supernatant were separated by centrifugation at 3000 rpm in calibrated 
polypropylene (Falcon) tubes; weight and volume of each phase were measured [18]. 
Preparation of microspheres 
This method was detailed elsewhere [18]. PLGA 50/50 (0.75 g) was dissolved in methylene chloride (37.5 g) in 
an Erlenmeyer flask fitted with a rubber septum. This solution was poured into a high beaker covered by a 
plastic sheet, thermostated at 20°C and stirred at 800 rpm. The aqueous solution containing BSA (7.5 mg) or α-
thrombin (7.5 mg) (200 µl) was then added. After a few seconds, the stirring rate was decreased at 200 rpm and 
the (1000 cSt) silicone oil was added to the dispersion with a polypropylene syringe. Finally, the phase separated 
system was transferred into a high beaker containing 500 ml of heptane, thermostated at 20°C. The stirring rate 
was set at 300 rpm. After half an hour, the microparticles were washed with 500 ml of heptane and dried by 
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lyophilisation. These 'standard' conditions were systematically used in this study, excepted for the four 
aforementioned processing parameters that were changed independently. 
Shape and surface of the microparticles were observed by scanning electron microscopy ( Jeol JSM-840 A 
Technics Co, Ltd, Tokyo). Dry microcapsules were previously coated with a ca. 30 nm Au-Pd film under 
reduced pressure (Balzer, SCP-20). 
Mean diameter and size distribution of the microparticles previously suspended in a saline buffer were analyzed 
with a Malvern Instrument (Mastersizer, S3:01; Worcestershire, U.K.). 
 
3. Results and discussion 
3.1. Effect of volume of the dispersed aqueous phase 
The observation by optical microscopy of the microparticles prepared according to the standard coacervation 
technique [16,17] shows that a large part of them has failed to encapsulate the dispersed aqueous phase labelled 
with a dye. This observation may be the result of an excess of coacervate with respect to the dispersed aqueous 
phase or to a mismatching of the water-coacervate, water-supernatant and coacervate-supernatant interfacial 
tensions, as discussed by Torza and Mason [19]. 
 
Table 1: Stability window for the PLGA 50:50/silicone oil (1000 cSt)/CH2C12 system in relation to the relative 
volume of the aqueous phase 







awt% of silicone oil with respect to the organic phase(oil + polymer+ CH2C12). 
Since we have shown elsewhere that the interplay of the interfacial tensions in the standard system under 
investigation was favourable to the coating of the dispersed aqueous phase by the coacervate [18], it is 
worthwhile to consider the possible effect of an increasing volume of the aqueous phase at a constant weight of 
the coating polymer. In this respect, microspheres have been prepared in the presence of increasing volumes of 
dispersed aqueous phase. However, it has been ascertained in a preliminary step, that the phase diagram and 
particularly the 'stability window' of the ternary system is not modified by this parameter. It must be recalled that 
the stability window is a domain in the phase diagram where the dispersed aqueous phase is efficiently coated by 
the coacervate [13,16]. With respect to this window, when a defect or an excess of silicone oil is used, the coated 
aqueous droplets are unstable or aggregated, respectively. 
The phase diagram for PLGA 50/50 (2 wt% in CH2C12) and the 1000 cSt silicone oil has been established, as 
reported elsewhere [16], while changing the weight ratio of the dispersed aqueous phase and the organic phase 
(0.02; 0.04 and 0.12). 
Table 1 shows that the desolvation process is not significantly affected by the relative volume of the aqueous 
phase, since the relative amount of the silicone oil (compared to the organic solution) required to observe the 
'stability window' remains essentially unmodified. This merely indicates that the aqueous phase and the organic 
phase are immiscible, otherwise composition of the organic phase should be modified and the 'stability window' 
as well. Nevertheless, Table 1 shows that the 'stability window' gets narrower when the volume of the aqueous 
phase is increased, all the other conditions being kept constant. 
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Table 2: Mean size (µm) of final microparticles in relation to stirring rate on dispersion of an aqueous solution 
of BSA in the PLGA solution in CH2C12 prior to phase demixing 
Stirring rate ( rpm ) Mean size (µm) 
800 40.0±1.5 
600 40.2 ±2.2 
500 47.2±1.7 
400 51.5±1.9 
300 No microparticle 
 
There is accordingly an increased instability of the coated aqueous droplets when their volume is increased. This 
experimental parameter thus affects the second phase of the microencapsulation, i.e. the coating process. This 
conclusion is confirmed by the morphology of the final microspheres as observed by scanning electron 
microscopy. Fig. 1 shows that spherical microparticles are observed at the lower aqueous phase content, whereas 
the particles tend to be deformed when the relative amount of the dispersed aqueous phase is increased. 
Independently of this detrimental effect, it is reported that the proportion of microparticles loaded with an 
aqueous solution of indigo carmine increases with the aqueous phase content. At a 0.12 aqueous phase/organic 
phase weight ratio, the microparticles are homogeneously stained. At water contents exceeding 0.12, 
microparticles become brittle and they spontaneously release the encapsulated dye solution during filtration. This 
observation is not surprising, since an increasing amount of aqueous phase with respect to the coacervate must 
result in a thinner polymer coating around the encapsulated aqueous droplets. As a rough piece of information, it 
may be calculated that the surface area of aqueous droplets of an average size of 20 µm changes from 9 to 90 
dm2 when the water volume is increased from 0.3 to 3.0 ml. From previous data about the size distribution of the 
coacervate droplets formed in our standard conditions [18], the surface area of these droplets is ca. 30 dm2. 
Therefore, the coacervation phase which is in a large excess for 0.3 ml of aqueous phase to be coated is no 
longer enough to encapsulate 3 ml of aqueous droplets. 
3.2. Effect of the stirring rate 
The size distribution of microparticles is currently dependent on the stirring rate of the dispersion in the 
emulsion-evaporation technique [20,21]. Stirring should also affect the issue of the coacervation process, since 
the phase separated system consists of three immiscible liquid phases that tend to decrease rapidly the interfacial 
area by coalescence. Undoubtedly, the encapsulation efficiency and size of the final microspheres will change 
with the size distribution of the aqueous phase and the oil droplets, respectively. In order to discriminate the 
possible effect of these two populations of droplets on the encapsulation process, the stirring rate has been 
modified either just after the addition of the aqueous phase to the polymer solution (dispersion step) or during 
coacervation of the polymer solution (encapsulation step). In the first case, stirring rate should control the size 
distribution of the water-in-oil dispersion prior to the coating process. In the second case, average size of the 
coacervate droplets should also be controlled by the stirring rate. 
Actually, when an aqueous solution of BSA (10 wt% with respect to PLGA) is dispersed in the polymer solution 
at decreasing stirring rates (800-300 rpm), the size of the aqueous droplets is qualitatively seen to increase, and 
Table 2 confirms that the size of the final microparticles changes in the same direction. Although this average 
size is not very sensitive to the stirring rate in the range from 800-600 rpm, it increases significantly when the 
rate falls down to 400 rpm. Surprisingly enough, at a still lower speed, i.e. 300 rpm, no microsphere can be 
collected and the coacervate droplets precipitate. This lower critical stirring speed might indicate that kinetics of 
coating of the aqueous droplets by the coacervate is too slow or that bigger coated droplets become unstable. 
In a second series of experiments, the stirring rate has been kept constant during the aqueous phase dispersion 
(800 rpm), although it was changed during the addition of the silicone oil, i.e. the coacervation and coating steps. 
It is then observed that the stability of the coacervate droplets rapidly decreases, while their size increases as the 
stirring rate is decreased. At a stirring rate of 100 rpm or smaller, the coacervate tends to coalesce and to settle 
down. Table 3 shows that, in a parallel way, the mean size of the final microparticles changes in the same 
direction, which supports the assumption that the coacervate droplets are the main precursor for the 
microparticles and that one coacervate droplet tends to engulf one aqueous droplet [18]. 
As a result, the control of the average size of the microspheres in a range larger than 10-60 µm is not 
straightforward. 
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Fig. 1. Observation by scanning electron microscopy of microspheres prepared with an aqueous phase/organic 
phase wt ratio of 0.02 (a) and 0.12 (b). 
  
 
Table 3: Mean size ( µm) of final microparticles in relation to stirring rate on addition of silicone oil ( 1000 cSt) 
to promote PLGA coacervation 
Stirring rate (rpm) Mean size (µm) 
200 40.0±1.5 
180 43.1 ± 1.2 
150 48.2 ± 2.1 
130 58 ± 3.1 
100 No microparticle 
 
3.3. Effect of the addition rate of the silicone oil 
Kinetics of the phase separation step is an additional parameter that might influence the whole 
microencapsulation process that occurs under non-equilibrium conditions. Indeed, the instantaneous 
concentration of the coating polymer in the supernatant and coacervate phases might be at variance, depending 
on time. Furthermore, the molecular weight distribution of the coating polymer in each phase should depend on 
the rate of polymer precipitation, as stated by Iso et al. [22], and analyzed later by Heinrich and Wolf [23]. At 
sufficiently high precipitation rates, polymer coils shrink so quickly that chains are not properly distributed 
between the two phases and a non-equilibrium distribution may persist until the microsphere solidification 
occurs. These potential effects have prompted us to check whether the addition rate of the silicone oil, i.e. the 
demixing agent, may have an effect on the demixing process. 
Fig. 2 shows that the relative weight and volume of the coacervate with respect to the original polymer solution 
increase from 6.5 to 7.9% and from 5.35 to 6.6%, respectively, when the silicone oil, i.e. the phase separation 
promoter, is added at an increasing rate: 0.65-18 ml/min, respectively. These figures strongly support the 
conclusion by Heinrich and Wolf [23] that polymer coacervation is a non-equilibrated process whatever the way 
the phase separation is induced: cooling of the polymer solution in the study by Heinrich and Wolf [ 23 ] and 
addition of an immiscible polymer in this study. 
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In contrast to the two former processing parameters, the polymer precipitation rate has an effect on the size 
distribution of the coacervate droplets. Fig. 3 shows that this distribution is more uniform at a slower phase 
separation rate. This observation is actually in line with conclusions by Heinrich and Wolf [23] about the phase 
separation mechanism under non-equilibrium conditions. Under conditions close to the equilibrium, phase 
separation would occur by a nucleation and growth mechanism, prone to give dispersed phases of a 
homogeneous size. In contrast, a spinodal mechanism or a combination of these two mechanisms would prevail 
under fast coacervation conditions, accounting for a completely different size distribution of the dispersed phase. 
 
Fig. 2. Relative weight (%) and volume (%) of the coacervate in relation to the addition rate of the silicone oil 
(ml/min). 
 
Fig. 3. Size distribution of the coacervate droplets observed at two different addition rates of the silicone oil; (a) 
18ml/min and (b) 5.7 ml/ min. 
 
Table 4: Mean size of PLGA50:50microparticles (µm) in relation to addition rate of silicone oil and 
encapsulated proteins 
Addition rate of silicone oil 
(ml/min) 
BSA Thrombin 
18 40.0±1.5 38.3±1.1 
5.70 39.1 ± 1.1 38.0 ± 2.0 
1.40 50.9 + aggregates No microparticles 
0.65 53.1 + aggregates No microparticles 
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The critical addition rate of the silicone oil below which no microparticle is formed actually depends on the 
proteinic drug dissolved in the dispersed aqueous phase: 0.65 ml/min for a BSA solution and 5.7 ml/ min for the 
α-thrombin solution (Table 4). This observation highlights the effect of the interplay of the inter-facial tensions 
between the three phases: aqueous droplets, coacervate and supernatant phase on the encapsulation efficiency. 
Indeed BSA is known for a surface activity [24], so that the interfacial tension of a BSA aqueous solution against 
the coacervate and the organic supernatant phase, respectively, must be different compared to an α-thrombin 
aqueous solution, all the other conditions being the same. Unfortunately, as reported elsewhere [17], these 
interfacial tensions cannot be measured due to the systematic formation of a thin film at the interface as a result 
of the interfacial coprecipitation of the protein and the coating polyester.  
The surface characteristic features of the microparticles also depend on the polymer precipitation rate. As shown 
in Fig. 4 and in agreement with previous data published by Donbrow et al. [25], the particle surface is smoother 
when the silicone oil is added more slowly. Consistently with Fig. 3 for the coacervate droplets, Fig. 5 confirms 
a much narrower size distribution of the final microparticles centered around 40 µm when the polymer 
precipitation is slow. Furthermore, when the addition of the silicone oil is fast, very small particles are observed 
in the range of 1-2 µm ( Fig. 5a), the adsorption of which on the surface of the large particles is responsible for 
the micrographs reported in Fig. 4a. The parallel change in the size distribution of the coacervate droplets and the 
final microparticles when the rate of polymer coacervation is changed gives an additional credit to the origin of 
the microparticles that has to be found in the coacervate droplets. 
From all these observations, it appears that microencapsulation by coacervation is a complex process that 
depends on the interplay of several kinetic parameters. If polymer precipitation is too fast compared to polymer 
deposition on the surface of the dispersed aqueous droplets, the encapsulation efficiency will inevitably be poor. 
Nevertheless, there is a lower critical coacervation rate below which the encapsulation does not occur at all. It 
must be pointed out that coating of the dispersed aqueous phase by the coacervate will be as difficult as the 
coacervate viscosity will be high. However, in addition to this kinetic effect, a high coacervate viscosity leads to 
a broad size distribution of the coacervate droplets and to microparticles covered with buds. The interfacial 
tension between the coexisting phases may not be ignored as a thermodynamic control of the encapsulation. It is 
worth noting that the silicone oil content of the final microparticles is far from being negligible (4.5 wt%) as 
measured by NMR. 
 
Fig. 4. Observation by SEM of BSA containing microparticles prepared at a silicone oil addition rate of (a) 18 
ml/min, (b) 5.7 ml/ min. 
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Fig. 5. Size distribution of BSA containing microparticles prepared with a silicone oil added at (a) 18 ml/min 




This study has highlighted the effect that several formulation parameters can have on microencapsulation by 
coacervation of a coating polymer solution. This process proceeds along three steps, i.e. phase separation of the 
coating polymer, adsorption of the coacervate on the dispersed phase and hardening of the coating, that occur so 
quickly that they are far from equilibrium and thus sensitive to kinetic influences. So, the addition rate of 
silicone oil, i.e. the coacervation promoter, has a significant effect on the final microspheres and in the extreme, 
it can prevent encapsulation from occurring. The ratio of the dispersed aqueous phase to the oil phase and the 
stirring rate when dispersion is carried out also modify the fate of the coacervate droplets and thus the 
encapsulation efficiency. The protein drug to be encapsulated also affects the coating step, because it changes the 
interfacial tension of the dispersed solution against organic phases. Furthermore, it has been shown elsewhere 
that the protein can interact with the coating polymer and promote an interfacial complexation [10]. 
Several experimental observations point out that the coacervate droplets are the precursor for the final 
microspheres. Efficiency of microencapsulation by coacervation thus appears to be limited to rather critical 
conditions in terms of the system composition and kinetics of formulation and implementation. As a result, the 
main microparticle characteristics can only be modified in a limited range, compared to other available 
techniques, such as double emulsion (W/O/W) evaporation, which is a more versatile technique. 
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